Literature DB >> 27299046

Isolated Mucormycotic Spondylodiscitis of Lumbar Spine-A Rare Case Report.

Shailesh Hadgaonkar1, Kunal Shah1, Shekhar Bhojraj2, Abhay Nene2, Ashok Shyam1.   

Abstract

INTRODUCTION: Mucormycosis is life threatening infection rarely affecting musculoskeletal system and spinal involvement is extremely rare with only two cases reported in English literature. CASE REPORT: We present this rare case of spondylodiscitis with lumbar vertebral osteomyelitis due to mucormycosis in a patient with chronic kidney disease on haemodialysis diagnosed by CT guided biopsy and highlight its clinico -radiological presentation and management principles.
CONCLUSION: Thus, as the incidence of Mucorales infection increase due to increase in patients with predisposing factors, the unusual sites of affection increase. Treating clinician should have a high vigilance in patients with predisposing factors. Although there is dramatic improvement in the treatment modalities of mucormycosis, still the mortality is high. Early diagnosis is important to prevent dissemination and timely intervention in order to reduce morbidity and mortality. A well equipped multidisciplinary approach for clinico-radiological assessment and management is necessary.

Entities:  

Keywords:  Isolated; Mucor my costs; spine

Year:  2015        PMID: 27299046      PMCID: PMC4722592          DOI: 10.13107/jocr.2250-0685.275

Source DB:  PubMed          Journal:  J Orthop Case Rep        ISSN: 2250-0685


Introduction

Mucormycosis is a rare life –threatening opportunistic infection belonging to phylum zygomycosis. The name mucormycosis was used by R.D. Baker to designate mycosis caused by members of order mucorales [1]. Anatomically the site of invasive mucormycosis has been classified in six categories including rhinocerebral (most common), pulmonary, cutaneous, gastrointestinal, disseminated and uncommon rare forms such as osteomyelitis, peritonitis, endocarditis and renal infection [2]. Osteomyelitis due to mucormycosis have been described in tibia, femur, humerus, scapula, metacarpals, phalanges, sternum, cuboid, calcaneum, following tibial pin placement and anterior cruciate ligament repair[3]. Spinal involvement in mucormycosis is rare and only two cases have been reported till now in English literature[4,5]. Mucormycosis infection is most commonly seen in immuno compromised state with risk factors being uncontrolled diabetes mellitus in ketoacidosis, corticosteroids, trauma, burns, malignant hematologic disorder, organ transplantation, neonatal prematurity and malnourishment, illicit intravenous drug abuse, patients on hemodialysis and deferoxamine therapy(6). We present this rare case of spondylodiscitis with lumbar vertebral osteomyelitis due to mucormycosis in a patient with chronic kidney disease on haemodialysis diagnosed by CT guided biopsy and highlight its clinico –radiological presentation and management principles.

Case report

A 64 year old man presented with chronic low back pain which was continuous and dull aching without any radicular symptoms or diurnal variations accompanied with low grade fever and weight loss (about 14 kg) since 3 months. Patient was a known case of diabetes mellitus, hypertension and chronic kidney disease on maintenance haemodialysis twice a week. On examination, Patient was febrile and pale. Systemic examination was normal. On local examination, there was tenderness over lower lumbar vertebrae and the movements of lumbar spine were terminally restricted due to pain. Patient’s sensory and motor examinations were normal. Patient already had recent radiological investigations done by previous treating surgeon, so we didn’t perform fresh investigations. Radiograph of lumbo- sacral spine (figure 1) showed slightly decreased density at L4-5 level and spondylolisthesis L5-S1 level with normal disc space appearance. Magnetic resonance imaging of lower lumbar spine (non contrast) showed hypointense signal involving L4 and L5 vertebrae with anterolisthesis of L5 over S1 vertebrae (Figure 2a, 2b).
Figure 1

anteroposterior and lateral view of lumbo sacral spine

Figure 2a

T1w Images showing hypointense signal involving L4 and L5 verteebae with anterolisthesis of L5 over S1 vertebrae. 2b precontrast T2w Images showing hypointense signal involving L4 and L5 vertebrae

anteroposterior and lateral view of lumbo sacral spine T1w Images showing hypointense signal involving L4 and L5 verteebae with anterolisthesis of L5 over S1 vertebrae. 2b precontrast T2w Images showing hypointense signal involving L4 and L5 vertebrae Contrast MRI showed images demonstrating abnormal enhancement of L4 and L5 vertebrae without significant discal enhancement. Also enhancing soft tissue is noted anterior to L4-L5 disc. (Figure 3a, 3b, 4a, 4b)
Figure 3a & b

sagittal T1w images demonstrating abnormal enhancement of L4 and L5 vertebrae without significant discal enhancement. Also enhancing soft tissue is noted anterior to L4-L5 disc.

Figure 4a & b

axial T1w images demonstrating abnormal enhancement of L4 and L5 vertebrae without significant discal enhancement. Also enhancing soft tissue is noted anterior to L4-L5 discand in epidural region

sagittal T1w images demonstrating abnormal enhancement of L4 and L5 vertebrae without significant discal enhancement. Also enhancing soft tissue is noted anterior to L4-L5 disc. axial T1w images demonstrating abnormal enhancement of L4 and L5 vertebrae without significant discal enhancement. Also enhancing soft tissue is noted anterior to L4-L5 discand in epidural region Imaging features were more in favour of infective pathology. We then performed laboratory investigations which revealed infectious etiology with deranged renal function. Haemoglobin- 8g/dl, Erythrocyte sedimentation rate -120mm/h, C-reactive protein- 10, Total leucocyte count -15,000 with lymphocytosis, Random blood sugar -/dl, Serum Creatinine- 5g/dl and Blood urea nitrogen-120 mg/dl. With keeping infectious etiology in mind CT guided biopsy was performed under sedation. Post biopsy patient was advised bed rest, mild analgesics and supportive medical line of treatment. Histopathology of the biopsy material showed classical phylle of mucor in haematoxylin and eosin stain. Infiltration by acute inflammatory cells like polymorphs and eosinophils were also seen. This confirmed fungus mucor on microscopy. (Figure 5a and 5b). No other procedure was performed on the patient.
Figure 5a & b

haemotoxylinand eosin stain showing mucor organism

5Amagnification 100x

5B magnification 400x

haemotoxylinand eosin stain showing mucor organism 5Amagnification 100x 5B magnification 400x The prognosis of disease was explained in details to the patient and relatives. In view of the multiple comorbidities of the patient, conservative line of management was chosen. He was initated on Lipid formulation amphotericin B (LFAB). Renal function tests and leucocyte counts were monitored. Symptomatically the patient initially improved and the leucocyte counts decreased. Maintenance dialysis was carried out twice a week. But in the third week the general condition started deteriorating requiring vasopressors due to septicemic shock. He progressed into septicemia and multiorgan failure and eventually succumbed after one week of aggressive medical management.

Discussion

The most common portal of entry of mucor organism is by inhalation of spores in air. Also it can enter the body via breach in mucosa of the skin or ingestion (7). Musculoskeletal mucormycosis is caused by breach in the skin due to trauma or direct inoculation. Hematogenous spread causing osteomyelitis is extremely rare (7). Spinal involvement has been described in only two cases in English literature. The case described by Buruma et al had cervical spine involvement with tetraplegia and previous medical history of laryngectomy with partial hypopharyngectomy and radiotherapy, eventually patient died because of pulmonary embolus and diagnosis was made on post-mortem specimen(5). In case described by Chen et al, lumbar puncture was proposed to be the mechanism of introduction of fungi (4). In our case, the patient was immuno compromised but there was no history suggestive of inoculation of organism or systemic involvement of mucormycosis. Clinical features of mucormycosis depend on the site of involvement. The hallmark of condition is angioinvasion and localized destruction of tissues (7). Musculoskeletal symptoms are often neglected due to other co morbidities. Spinal involvement as seen in case of Buruma et al and Chen et al presented as localized pain and constitutional symptoms with associated numbness and weakness (4, 5). Our case also had similar clinical presentation. Majority of cases of mucormycosis presents in disseminated form because of angioinvasive nature of disease. Isolated lesions are rarely described with few cases reported in kidney, bone, heart, lung, brain, and gastro-intestinal tract (8, 9, 10). Our case presented as isolated lesion with no other organs involved except spine. On plain radiograph, spinal mucormycosis presents as hypodensity in involved vertebra (4). MRI scanning (non contrast)reveals a low intensity on Tl-weighted and patches of high intensity on T2-weighted images (4). Our case showed hypodensity in plain radiograph and hypointense signal in T1 and T2 images in noncontrast MRI. We also present findings of contrast MRI, which shows hyperintense signal in vertebral body without abnormal signal in disc space. Clinical features and radiographic manifestations are non specific and histopathology gives the definitive diagnosis (4). It is important to distinguish between mucorales and other fungi like fusarium, pseudallescheria and aspergillous species. The hyphae of mucorales organism typically are non septate, branching nondichotomously at right angles (4). The success of treatment of mucormycosis depends on early diagnosis, reversal of predisposing factors, surgical debridement and prompt antifungal therapy (6). The mainstay of medical management mainly is Amphotericin B, but it is nephrotoxic(11). Majority of patients have chronic kidney disease like in our patient, so cautious use is required. Lipid formation of Amphotericin B has significantly less nephrotoxicity and can be used in higher doses. Hence it has become cornerstone of treatment of mucormycosis. Recommended starting dose of LFAB is 5-7.5 mg/kg/day(11). Other drugs like Deferasirox (Iron chelator) or posaconazole are used as salvage options in cases of resistant disease or intolerance to Amphotericin B (12). Combination therapies of LFAB with deferasirox and LFAB-echinocandin have shown promising results in preclinical studies, but definitive trials are required to prove their efficacy(11). Mucorales organism is angioinvasive causing thrombosis of vessels leading to poor penetration of antifungal agents. Hence debridement of the necrotic part is very important for complete eradication of mucormycosis (12). Chen et al showed successful treatment of spinal mucormycosis with repeated debridements(4). In our case because of medical comorbidities, we could not perform debridement. Thus, as the incidence of Mucorales infection increase due to increase in patients with predisposing factors, the unusual sites of affection increase. Treating clinician should have a high vigilance in patients with predisposing factors. Although there is dramatic improvement in the treatment modalities of mucormycosis, still the mortality is high. Early diagnosis is important to prevent dissemination and timely intervention in order to reduce morbidity and mortality. A well equipped multidisciplinary approach for clinico-radiological assessment and management is necessary.

Conclusion

Mucormycosis of spine is a rare condition. Treating clinician should be aware of its predisposing factors and clinic oradio logical appearance. Early and prompt diagnosis decreases morbidity and mortality. Aggressive multi departmental approach is required for treatment of this lifethreatening condition. Clinical Messege Mucormycosis should be considered as an differential of atypical infection of spine. Proper clinicoradiological assessment is required for diagnosis. Aggressive multidepartmental approach is required for treatment of this lifethreatening condition.
  10 in total

1.  Pulmonary mucormycosis.

Authors:  R D BAKER
Journal:  Am J Pathol       Date:  1956 Mar-Apr       Impact factor: 4.307

2.  Mucormycosis spondylodiscitis after lumbar disc puncture.

Authors:  Fei Chen; Guohua Lü; Yijun Kang; Zeming Ma; Chang Lu; Bin Wang; Jin Li; Jun Liu; Haisheng Li
Journal:  Eur Spine J       Date:  2005-11-18       Impact factor: 3.134

3.  Isolated renal mucormycosis: an unusual cause of acute renal infarction in a boy with aplastic anaemia.

Authors:  R Sharma; G Shivanand; R Kumar; S Prem; H Kandpal; C J Das; M C Sharma
Journal:  Br J Radiol       Date:  2006-07       Impact factor: 3.039

4.  Vertebral osteomyelitis and epidural abcess due to mucormycosis, a case report.

Authors:  O J Buruma; H Craane; M W Kunst
Journal:  Clin Neurol Neurosurg       Date:  1979       Impact factor: 1.876

Review 5.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

6.  Gastrointestinal mucormycosis--an uncommon isolated mucormycosis.

Authors:  M C Sharma; S S Gill; S Kashyap; R Kataria; D K Gupta; P Sahni; S K Acharya
Journal:  Indian J Gastroenterol       Date:  1998 Oct-Dec

7.  Recent advances in the treatment of mucormycosis.

Authors:  Brad Spellberg; Ashraf S Ibrahim
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

8.  Isolated cerebral mucormycosis.

Authors:  Seong Rok Han; Chan Young Choi; Mee Joo; Choong Jin Whang
Journal:  J Korean Neurosurg Soc       Date:  2007-11-20

Review 9.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

Review 10.  Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.

Authors:  R M Prabhu; R Patel
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

  10 in total
  6 in total

1.  Mucormycosis of the Spine: A Case Report and Review of the Literature.

Authors:  Jaimin Patel; Zach Pennington; Andrew M Hersh; Bethany Hung; Daniel M Scuibba; Sheng-Fu L Lo
Journal:  Cureus       Date:  2022-03-29

Review 2.  Paraplegia secondary to disseminated mucormycosis: case report and literature review.

Authors:  Xiangjun Shi; Lei Qi; Boran Du; Xingchen Yao; Xinru Du
Journal:  BMC Infect Dis       Date:  2022-04-25       Impact factor: 3.667

3.  Spinal Mucormycosis.

Authors:  Kunal Shah; Abhay Nene
Journal:  J Glob Infect Dis       Date:  2017 Oct-Dec

4.  Black fungus outbreak in India - A direct consequence of COVID-19 surge: A myth or reality.

Authors:  Archana Sharma; Megha Bedi; Prachi Patel; Amarpreet Singh Arora
Journal:  Gondwana Res       Date:  2022-02-05       Impact factor: 6.051

5.  Mycobacteria Intracellulare Spondylodiscitis Presenting as Progressive Consecutive Vertebral Sclerosis: A Case Report.

Authors:  Kunal Shah; Gaurang Atodaria; Milind Patwardhan; Abhay Nene
Journal:  J Orthop Case Rep       Date:  2017 Nov-Dec

Review 6.  Epidemiology of Mucormycosis in India.

Authors:  Hariprasath Prakash; Arunaloke Chakrabarti
Journal:  Microorganisms       Date:  2021-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.